vs

Side-by-side financial comparison of Brookfield Asset Management Ltd. (BAM) and ResMed (RMD). Click either name above to swap in a different company.

ResMed is the larger business by last-quarter revenue ($1.4B vs $1.1B, roughly 1.3× Brookfield Asset Management Ltd.). Brookfield Asset Management Ltd. runs the higher net margin — 56.7% vs 27.6%, a 29.1% gap on every dollar of revenue.

Brookfield Asset Management Ltd. is a Canadian-American alternative asset manager. The company was founded in December 2022 as a spin-off of the asset management operations of Brookfield Corporation, and manages investments across real estate, infrastructure, renewable energy, private equity, and credit markets globally.

ResMed Inc. is a medical equipment company based in San Diego, California, and founded in Australia. It primarily provides cloud-connectable medical devices for the treatment of sleep apnea, chronic obstructive pulmonary disease (COPD), and other respiratory conditions. Resmed produced hundreds of thousands of ventilators and bilevel devices to help treat the respiratory symptoms of patients with COVID-19.

BAM vs RMD — Head-to-Head

Bigger by revenue
RMD
RMD
1.3× larger
RMD
$1.4B
$1.1B
BAM
Higher net margin
BAM
BAM
29.1% more per $
BAM
56.7%
27.6%
RMD

Income Statement — Q4 FY2025 vs Q4 FY2026

Metric
BAM
BAM
RMD
RMD
Revenue
$1.1B
$1.4B
Net Profit
$615.0M
$392.6M
Gross Margin
61.8%
Operating Margin
84.2%
34.6%
Net Margin
56.7%
27.6%
Revenue YoY
11.0%
Net Profit YoY
13.9%
EPS (diluted)
$2.68

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
BAM
BAM
RMD
RMD
Q2 26
$1.4B
Q4 25
$1.1B
$1.4B
Q3 25
$974.0M
$1.3B
Q2 25
$931.0M
$1.3B
Q1 25
$954.0M
$1.3B
Q4 24
$1.3B
Q3 24
$873.0M
$1.2B
Q2 24
$821.0M
$1.2B
Net Profit
BAM
BAM
RMD
RMD
Q2 26
$392.6M
Q4 25
$615.0M
$392.6M
Q3 25
$692.0M
$348.5M
Q2 25
$584.0M
$379.7M
Q1 25
$507.0M
$365.0M
Q4 24
$344.6M
Q3 24
$537.0M
$311.4M
Q2 24
$124.0M
$292.2M
Gross Margin
BAM
BAM
RMD
RMD
Q2 26
61.8%
Q4 25
61.8%
Q3 25
61.5%
Q2 25
60.8%
Q1 25
59.3%
Q4 24
58.6%
Q3 24
58.6%
Q2 24
58.5%
Operating Margin
BAM
BAM
RMD
RMD
Q2 26
34.6%
Q4 25
84.2%
34.6%
Q3 25
79.1%
33.4%
Q2 25
70.8%
33.7%
Q1 25
61.0%
33.0%
Q4 24
32.5%
Q3 24
72.5%
31.6%
Q2 24
80.4%
31.2%
Net Margin
BAM
BAM
RMD
RMD
Q2 26
27.6%
Q4 25
56.7%
27.6%
Q3 25
71.0%
26.1%
Q2 25
62.7%
28.2%
Q1 25
53.1%
28.3%
Q4 24
26.9%
Q3 24
61.5%
25.4%
Q2 24
15.1%
23.9%
EPS (diluted)
BAM
BAM
RMD
RMD
Q2 26
$2.68
Q4 25
$2.68
Q3 25
$2.37
Q2 25
$2.58
Q1 25
$2.48
Q4 24
$2.34
Q3 24
$2.11
Q2 24
$1.97

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
BAM
BAM
RMD
RMD
Cash + ST InvestmentsLiquidity on hand
$1.6B
$1.4B
Total DebtLower is stronger
$663.8M
Stockholders' EquityBook value
$8.9B
$6.3B
Total Assets
$17.0B
$8.5B
Debt / EquityLower = less leverage
0.11×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
BAM
BAM
RMD
RMD
Q2 26
$1.4B
Q4 25
$1.6B
$1.4B
Q3 25
$1.1B
$1.4B
Q2 25
$480.0M
$1.2B
Q1 25
$332.0M
$932.7M
Q4 24
$521.9M
Q3 24
$426.4M
Q2 24
$10.0M
$238.4M
Total Debt
BAM
BAM
RMD
RMD
Q2 26
$663.8M
Q4 25
$403.9M
Q3 25
$408.7M
Q2 25
$658.4M
Q1 25
$663.1M
Q4 24
$662.9M
Q3 24
$667.6M
Q2 24
$697.3M
Stockholders' Equity
BAM
BAM
RMD
RMD
Q2 26
$6.3B
Q4 25
$8.9B
$6.3B
Q3 25
$8.5B
$6.1B
Q2 25
$8.5B
$6.0B
Q1 25
$8.5B
$5.5B
Q4 24
$5.3B
Q3 24
$9.0B
$5.2B
Q2 24
$3.2B
$4.9B
Total Assets
BAM
BAM
RMD
RMD
Q2 26
$8.5B
Q4 25
$17.0B
$8.5B
Q3 25
$16.5B
$8.3B
Q2 25
$16.1B
$8.2B
Q1 25
$15.0B
$7.6B
Q4 24
$7.1B
Q3 24
$7.2B
Q2 24
$4.2B
$6.9B
Debt / Equity
BAM
BAM
RMD
RMD
Q2 26
0.11×
Q4 25
0.06×
Q3 25
0.07×
Q2 25
0.11×
Q1 25
0.12×
Q4 24
0.13×
Q3 24
0.13×
Q2 24
0.14×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
BAM
BAM
RMD
RMD
Operating Cash FlowLast quarter
$562.0M
Free Cash FlowOCF − Capex
FCF MarginFCF / Revenue
Capex IntensityCapex / Revenue
Cash ConversionOCF / Net Profit
0.91×
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
BAM
BAM
RMD
RMD
Q2 26
Q4 25
$562.0M
$339.7M
Q3 25
$745.0M
$457.3M
Q2 25
$529.0M
$538.8M
Q1 25
$265.0M
$578.7M
Q4 24
$308.6M
Q3 24
$567.0M
$325.5M
Q2 24
$159.0M
$440.1M
Free Cash Flow
BAM
BAM
RMD
RMD
Q2 26
Q4 25
$311.2M
Q3 25
$414.4M
Q2 25
$508.2M
Q1 25
$557.9M
Q4 24
$288.0M
Q3 24
$307.7M
Q2 24
$415.2M
FCF Margin
BAM
BAM
RMD
RMD
Q2 26
Q4 25
21.9%
Q3 25
31.0%
Q2 25
37.7%
Q1 25
43.2%
Q4 24
22.5%
Q3 24
25.1%
Q2 24
33.9%
Capex Intensity
BAM
BAM
RMD
RMD
Q2 26
Q4 25
2.0%
Q3 25
3.2%
Q2 25
2.3%
Q1 25
1.6%
Q4 24
1.6%
Q3 24
1.5%
Q2 24
2.0%
Cash Conversion
BAM
BAM
RMD
RMD
Q2 26
Q4 25
0.91×
0.87×
Q3 25
1.08×
1.31×
Q2 25
0.91×
1.42×
Q1 25
0.52×
1.59×
Q4 24
0.90×
Q3 24
1.06×
1.05×
Q2 24
1.28×
1.51×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

BAM
BAM

Incentive Fees$452.0M42%
Infrastruture$332.0M31%
Private Equity$174.0M16%
Renewable Power And Transition$66.0M6%
Other$47.0M4%
Management And Advisory Fees$14.0M1%

RMD
RMD

Segment breakdown not available.

Related Comparisons